Skip to main content

Table 6 Treatment outcomes of with platinum vs. without platinum

From: Gemcitabine-based versusfluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study

 

With Platinum

Without Platinum

P value

Number of patients

177

66

 

RR (%)

20.6

12.7

0.169

DCR (%)

60.6

46.0

0.049

PFS (months)

4.4 (95% CI, 3.7–5.1)

3.3 (95% CI, 2.3–4.3)

0.887

OS (months)

8.1 (95% CI, 7.0–9.3)

10.6 (95% CI, 7.9–13.2)

0.257

  1. RR, response rate; DCR, disease control rate; PFS, progression free survival; CI, confidence interval; OS, overall survival